You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.
On February 24, 2022, the Delhi High Court Intellectual Property Rights Division Rules, 2022 and the High Court of Delhi Rules Governing Patent Suits, 2022 were published in the O…
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
The American International University-Bangladesh (AIUB) celebrated World Intellectual Property (IP) Day 2026 by organizing a seminar and a rally on April 26, 2026, in line with the global theme “IP and Sports: Ready, Set, Innovate.” The seminar, titled “Intellectual Property in Sports: Legal and Commercial Intersectio…
Universiti Kebangsaan Malaysia (UKM) has been awarded the silver medal in the Best Intellectual Property Management category at the 2026 National Intellectual Property Awards (AHIN), organized by the Intellectual Property Corporation of Malaysia (MyIPO). UKM was the only higher education institution to reach the final…
On April 21, 2026, China’s Supreme People’s Court (SPC) published its Annual Report on Legal Application Issues in Intellectual Property Cases of Courts Nationwide (2025) (全国法院知识产权案件法律适用问题年度报告(2025)摘要), identifying 45 legal application issues drawn from intellectual property cases concluded by courts at all levels dur…
Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND Charles Feng of Tahota Law Firm concludes a two-part series on intellectual property protection in China by looking at copyright, unfair competition, and a change to the appeals procedure for technology-related disputes
Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biopharma and Genevant Sciences. The lawsuits alleged that Moderna’s vaccine relied on patented lipid nanoparticle delivery systems, a technolog…
The U.S. Supreme Court concluded its 2023-24 term with significant decisions impacting intellectual property law, including a unanimous ruling on the Lanham Act’s name clause and a split decision on the timing of copyright damages. As the 2024-25 term begins, the Court has agreed to hear additional IP cases while decl…